G
Genedrive PLC
LSE:GDR
Genedrive PLC
LSE:GDR
Price:
1.65 GBX
7.84%
Market Closed
Updated:
Jun 8, 2024
Genedrive PLC
Total Equity
|
Genedrive PLC
Total Equity Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Genedrive PLC
LSE:GDR
|
Total Equity
£1.5m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Equity
£643.9m
|
CAGR 3-Years
51%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Total Equity
£20.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Total Equity
£40.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Total Equity
£90.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Total Equity
£34.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
54%
|
CAGR 10-Years
47%
|
See Also
What is Genedrive PLC's Total Equity?
Total Equity
1.5m
GBP
1.5m
GBP
Based on the financial report for Dec 31, 2023, Genedrive PLC's Total Equity amounts to 1.5m GBP.
What is Genedrive PLC's Total Equity growth rate?
Total Equity CAGR 10Y
-18%
-18%
Over the last year, the Total Equity growth was -56%. The average annual Total Equity growth rates for Genedrive PLC have been -34% over the past three years , and -18% over the past ten years .
You don't have any saved screeners yet
